期刊文献+

我国制药企业技术创新 被引量:1

Pharmaceutical Industry's Technical Innovation of Our Country
在线阅读 下载PDF
导出
摘要 技术创新的能力和效率,是制约医药制造企业盈利能力的重要因素。针对我国制药企业因创新能力不足而影响竞争力的现状,提出了要在基础研究、应用研究和产业化等领域技术创新投入、增强企业与科研机构之间的合作、推进医药企业的产权多元化进程等多项对策和建议。 The ability and efficiency of technical innovation is the most important factor of the pharmaceutical enterprise' s profit ability. The present situation of Chinese pharmaceutcal industry' s competition is in the lack of innovative ability. In this article, we put forward to and suggestions. For example, in the realm of basic research, applied research and industrialization, we should add the input of technical innovation on the basis of present level and should enhance the cooperation between the big enterprise and scientific research institution ; we should advance the course of the enterprise' s property right multi - industry.
出处 《河北理工大学学报(社会科学版)》 2006年第1期84-86,97,共4页 Journal of Hebei Polytechnic University:Social Science Edition
关键词 制药企业 技术创新 对策 pharmaceutical industry technical innovation countermeasures
  • 相关文献

参考文献4

二级参考文献6

共引文献37

同被引文献18

  • 1顾海,卫陈.中国医药产业集中度实证研究[J].南京社会科学,2006(11):34-39. 被引量:26
  • 2TODD J W.The pharmaceutical industry[J].British Med-ical Journal,1958,10(4):846-849.
  • 3JANSSON S-O,VESSMAN J.Trends in product analysisfor research in the pharmaceutical industry[J].Mikro-chimica Acta,1991,(1):103-112.
  • 4MAHLICH J C,ROEDIGER-SCHLUGA T.The chan-ging nature of pharmaceutical R&D-opportunities for Asia[J].Management of Technological Innovation and R&D,2001(3):1-9.
  • 5GIULIO BOTTAZZI,ANGELO SECCHI.Growth andDiversification Patterns of the Worldwide PharmaceuticalIndustry[J].Review of Industrial Organization,2005,3(2):195-216.
  • 6GRILICHES Z,COCKBURN I.Generics and new goods inpharmaceutical price indexes[J].American Economic Re-view,1994,5(84):1213-1232.
  • 7ALEXANDER D L,FLYNN J E,LINKINS L A.Innova-tion,R&D productivity,and global market share in thepharmaceutical industry[J].Review of Industrial Organi-zation,1995(2):197-207.
  • 8ACEMOGLU D,LINN J.Market size in innovation:theo-ry and evidence from the pharmaceutical industry[J].Quarterly Journal of Economics,2004,8(3):1049-1090.
  • 9GEIJO F.Quality management in analytical R&D in thepharmaceutical industry:building quality from GLP[J].Accreditation and Quality Assurance,2000(1):16-20.
  • 10NAIR M D.TRIPS,WTO and IPR:impact of Indian Pa-tent Act 2005on Indian pharmaceutical industry[J].Jour-nal of Intellectual Property Rights,2010,15(6):474-476.

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部